NVIDIA commits $1 billion to enhance U.S. scientific research and leadership in super intelligence and quantum computing over five years.
Quiver AI Summary
NVIDIA has announced a $1 billion commitment over the next five years to advance super intelligence research and development in the U.S., focusing on key areas like quantum computing, healthcare, and energy security. This announcement was made during the Science: A New Golden Age event in Washington, D.C., attended by U.S. officials and industry leaders. Jensen Huang, NVIDIA's CEO, highlighted this investment as a means to enhance U.S. scientific and industrial leadership, thereby creating jobs and opportunities. As part of the initiative, NVIDIA will collaborate with higher education institutions and support various national lab projects, further strengthening its two-decade partnership with U.S. national laboratories. This investment aligns with the Genesis Mission, aimed at bolstering American technological advancements.
Potential Positives
- NVIDIA's commitment of $1 billion illustrates significant investment in advancing U.S. scientific research and leadership in critical fields such as quantum computing, healthcare, and energy security.
- The announcement enhances NVIDIA’s position as a key industry partner in the Genesis Mission, highlighting its long-term collaboration with national labs and strengthening its reputation in public-private partnerships.
- This initiative is expected to accelerate breakthroughs in scientific fields, potentially leading to innovations that create jobs and economic opportunities in the U.S.
- By inviting collaboration from the science community, NVIDIA positions itself as a leader in fostering innovation and advancements in super intelligence and technology infrastructure.
Potential Negatives
- The $1 billion commitment may strain NVIDIA's financial resources, potentially impacting its operational flexibility or other investments.
- Forward-looking statements highlight significant risks and uncertainties that could materially affect the company's ability to achieve its commitments and expectations.
- There may be public scrutiny regarding the motivations behind the investment, particularly given its political context, which could affect public perception.
FAQ
What is NVIDIA's recent investment in U.S. science?
NVIDIA has committed $1 billion over five years to advance super intelligence research in crucial fields like quantum computing and healthcare.
When was the announcement made?
The announcement was made during the Science: A New Golden Age event in Washington, D.C., on October 8, 2026.
How will NVIDIA's investment benefit scientific research?
The investment aims to enhance U.S. scientific capabilities by supporting higher education institutions and cloud service providers for government missions.
What is the Genesis Mission?
The Genesis Mission is an initiative by the U.S. Office of Science and Technology Policy, with NVIDIA as a key industry partner in its expansion.
How long has NVIDIA been collaborating with national labs?
NVIDIA has collaborated with U.S. national labs for over two decades, focusing on advancing technological leadership and scientific research.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$NVDA Insider Trading Activity
$NVDA insiders have traded $NVDA stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- MARK A STEVENS has made 0 purchases and 21 sales selling 6,121,740 shares for an estimated $1,353,730,171.
- TIMOTHY S. TETER (EVP, General Counsel and Sec) has made 0 purchases and 6 sales selling 60,460 shares for an estimated $13,323,047.
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 34,918 shares for an estimated $7,648,632.
- STEPHEN C NEAL sold 15,500 shares for an estimated $3,343,863
- JOHN DABIRI sold 625 shares for an estimated $133,750
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NVDA Revenue
$NVDA had revenues of $96.2B in Q2 2027. This is an increase of 105.85% from the same period in the prior year.
You can track NVDA financials on Quiver Quantitative's NVDA stock page.
You can access data on NVDA stock through the Quiver Quantitative API.
$NVDA Congressional Stock Trading
Members of Congress have traded $NVDA stock 20 times in the past 6 months. Of those trades, 7 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOHN MCGUIRE has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/18, 04/15 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 07/17 and 2 sales worth up to $30,000 on 08/18, 04/14.
- SENATOR SHELDON WHITEHOUSE has traded it 5 times. They made 0 purchases and 5 sales worth up to $615,000 on 08/13, 06/30, 05/08.
- SENATOR CORY A. BOOKER sold up to $50,000 on 08/11.
- REPRESENTATIVE SAM LICCARDO sold up to $50,000 on 07/21.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
- REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $45,000 on 06/26 and 0 sales.
- REPRESENTATIVE MICHAEL A. RULLI purchased up to $15,000 on 06/25.
- REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
- REPRESENTATIVE DANIEL MEUSER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 05/27, 04/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$NVDA Hedge Fund Activity
We have seen 3,138 institutional investors add shares of $NVDA stock to their portfolio, and 2,418 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 449,404,578 shares (+inf%) to their portfolio in Q2 2026, for an estimated $89,921,362,012
- INVESCO LTD. added 186,832,782 shares (+130.9%) to their portfolio in Q2 2026, for an estimated $37,383,371,350
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 160,214,733 shares (+inf%) to their portfolio in Q2 2026, for an estimated $32,057,365,925
- SG AMERICAS SECURITIES, LLC added 62,298,007 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,465,208,220
- FMR LLC added 32,198,580 shares (+3.2%) to their portfolio in Q2 2026, for an estimated $6,442,613,872
- CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM removed 22,264,066 shares (-32.6%) from their portfolio in Q2 2026, for an estimated $4,454,816,965
- BARCLAYS PLC removed 22,252,692 shares (-26.8%) from their portfolio in Q2 2026, for an estimated $4,452,541,142
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NVDA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 05/21/2026
To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.
$NVDA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 22 analysts offer price targets for $NVDA in the last 6 months, with a median target of $312.5.
Here are some recent targets:
- Jack Zhou from China Renaissance set a target price of $319.0 on 06/05/2026
- N. Quinn Bolton from Needham set a target price of $270.0 on 06/02/2026
- Gil Luria from DA Davidson set a target price of $300.0 on 06/01/2026
- Ivan Feinseth from Tigress Financial set a target price of $425.0 on 05/27/2026
- Srini Pajjuri from RBC Capital set a target price of $270.0 on 05/21/2026
- Timothy Arcuri from UBS set a target price of $280.0 on 05/21/2026
- William Stein from Truist Securities set a target price of $307.0 on 05/21/2026
Full Release
News Summary:
- NVIDIA announces commitments valued at $1 billion to advance U.S. science over the next five years, at a Washington event convening U.S. officials, industry leaders and members of the science community.
- This builds on longstanding collaboration between NVIDIA and national labs, spanning two decades.
SANTA CLARA, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NVIDIA today announced commitments valued at $1 billion to build out the United States’ capacity for super intelligence research and development in fields critical for U.S. leadership, including quantum computing, healthcare and energy security.
The announcement was made during the Science: A New Golden Age event in Washington, D.C., where U.S. officials, industry leaders and members of the science community convened on the public-private collaborations needed to bolster scientific exploration.
“President Trump’s Genesis Mission is launching a new golden age of American discovery,” said Jensen Huang, founder and CEO of NVIDIA. “With a $1 billion investment, NVIDIA is putting advanced Super Intelligence in the hands of America’s scientists to accelerate breakthroughs in medicine, energy and materials. This is how America turns scientific leadership into industrial leadership, and innovation into jobs and opportunity for generations.”
During the event, the U.S. Office of Science and Technology Policy celebrated the expansion of the Genesis Mission, of which NVIDIA is a leading industry partner. In response, NVIDIA has invited members of the science community to collaborate in R&D using compute and super intelligence infrastructure resources to accelerate scientific discovery and promote U.S. innovation.
Strengthening US Leadership in Scientific Discovery
Over the next five years, NVIDIA will commit $1 billion to the advancement of super intelligence for science and quantum computing across the U.S. through support of the nation’s higher-education research institutions, investments in accelerating American quantum leadership and support for cloud service providers bolstering U.S. government mission needs.
NVIDIA is also a collaborator on a number of the phase 2 Genesis Mission awards announced today at the event, including projects in quantum computing, fusion, accelerator design and microelectronics.
NVIDIA has collaborated with U.S. national labs for more than two decades. Last year, it announced its partnership with the U.S. Department of Energy (DOE) on the Genesis Mission, which includes NVIDIA’s work to build the department’s largest supercomputer for scientific research at Argonne National Laboratory. This is in addition to supporting seven new systems across Argonne and Los Alamos National Laboratories, accelerating the DOE’s mission of driving technological leadership.
About NVIDIA
NVIDIA
(NASDAQ: NVDA) is the world leader in AI and accelerated computing.
For further information, contact:
Corporate Communications
NVIDIA Corporation
[email protected]
Certain statements in this press release including, but not limited to, statements as to: expectations with respect to NVIDIA’s commitments to advance US science over the next five years; expectations with respect to growth, performance, availability, and benefits of NVIDIA’s products, services and technologies, and related trends and drivers; expectations with respect to NVIDIA’s third party arrangements, including with its collaborators and partners; expectations with respect to technology developments, and related trends and drivers; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing products and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; NVIDIA’s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on NVIDIA’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, and other NVIDIA product and service names are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries and regions. Other company, product, and service names may be trademarks of the respective companies with which they are associated.